Source: Medical Device Network

BioIntellisense: BioInteliSense remote cardiac device cuts hospital time in trial

The BioInteliSense study found that the company's device was able to cut hospitalisations and alert clinicians ahead of adverse events. The post BioInteliSense remote cardiac device cuts hospital time in trial appeared first on Medical Device Network.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
James Mault's photo - Chairman & CEO of BioIntellisense

Chairman & CEO

James Mault

CEO Approval Rating

86/100

Read more